Global Single-use Bioreactors Market Size By Type (Mammalian Cell, Bacterial Cell), By Application (R & D, Biopharmaceutical Manufacturers), By Region, And Segment Forecasts, 2023 to 2032

The Global Single-use Bioreactors Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 11.6 billion by 2031, expanding at a CAGR of 13.8% from 2023 to 2031. This market is witnessing significant growth due to increasing demand for biologics and biosimilars, rising adoption of single-use technologies in biopharmaceutical production, and cost advantages associated with disposable systems. Single-use bioreactors are widely used in upstream bioprocessing owing to their flexibility, scalability, and reduction in risk of cross-contamination.

Drivers:

1. Rising Demand for Biopharmaceuticals:

The increasing global burden of chronic diseases has led to growing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and cell & gene therapies. Single-use bioreactors offer a more flexible, rapid, and cost-effective solution for manufacturing these biologics, driving their adoption in the industry.

2. Reduced Risk of Contamination:

Single-use systems eliminate the need for cleaning and sterilization, significantly reducing the risk of product cross-contamination and ensuring regulatory compliance, especially in multi-product facilities.

3. Lower Operational Costs and Increased Efficiency:

By eliminating cleaning validation and reducing setup times, single-use bioreactors minimize labor and utility costs, enhancing productivity in both clinical and commercial production settings.

Restraints:

1. Limitations in Large-scale Manufacturing:

Single-use bioreactors are typically restricted in volume capacity (commonly up to 2000L), which limits their application in large-scale manufacturing, particularly in high-demand commercial settings.

2. Environmental Concerns:

The disposable nature of these systems contributes to plastic waste generation, raising sustainability concerns. Regulatory scrutiny and eco-conscious initiatives could slow adoption in environmentally sensitive regions.

Opportunity:

1. Emerging Cell and Gene Therapy Applications:

With the rise of personalized medicine, particularly cell and gene therapies, the demand for flexible, small-batch manufacturing is accelerating. Single-use bioreactors are well-suited for such applications, offering scalability and contamination-free processing.

2. Expansion in Emerging Markets:

Rapid developments in pharmaceutical infrastructure across Asia-Pacific and Latin America, coupled with supportive regulatory environments, are providing lucrative opportunities for global market players.

Market by System Type Insights:

Based on system type, the Stirred-tank Single-use Bioreactors segment held the largest market share in 2023. These bioreactors are widely used due to their similarity to traditional stainless-steel systems, ease of integration, and scalability. The Wave-induced Motion Bioreactors segment is also gaining traction, especially in early-stage R&D and seed culture expansion.

Market by End-use Insights:

In terms of end-use, the Biopharmaceutical Companies segment dominated the market in 2023, accounting for more than 55% of global revenue. These companies are rapidly adopting single-use systems to enhance flexibility, minimize downtime, and meet the increasing demand for diverse biologic drugs. The Contract Manufacturing Organizations (CMOs) segment is projected to grow at the highest CAGR due to the rising trend of outsourcing drug development and manufacturing.

Market by Regional Insights:

North America led the global market in 2023, driven by strong biopharmaceutical manufacturing infrastructure, high R&D expenditure, and early adoption of single-use technologies. Asia-Pacific is expected to witness the highest growth rate over the forecast period, fueled by increasing biomanufacturing capacity in China, India, and South Korea, along with supportive government initiatives and growing domestic demand for biologics.

Competitive Scenario:

Key players in the global single-use bioreactors market include Sartorius AG, Thermo Fisher Scientific Inc., Danaher Corporation (Cytiva), Merck KGaA, Eppendorf AG, PBS Biotech Inc., Applikon Biotechnology, Cellexus Ltd, and ABEC Inc. Companies are focusing on strategic collaborations, capacity expansion, and product innovation to strengthen their market positions.

Scope of Work – Global Single-use Bioreactors Market

Report Metric Details

Market Size (2023) USD 4.1 Billion

Projected Market Size (2031) USD 11.6 Billion

CAGR (2023–2031) 13.8%

Market Segments By System Type (Stirred-tank, Wave-induced Motion), By End-use (Biopharmaceutical Companies, CMOs, Academic & Research Institutes), By Region

Growth Drivers Increasing demand for biologics, cost efficiency, reduced risk of contamination

Opportunities Cell & gene therapy production, growth in emerging markets

Key Market Developments:

June 2023: Sartorius AG expanded its single-use bioreactor portfolio with the launch of a new line of scalable systems designed for both seed train and commercial manufacturing.

September 2023: Thermo Fisher Scientific introduced a fully automated single-use bioreactor platform integrated with real-time process analytics.

January 2024: Danaher’s Cytiva division announced a partnership with a biotech start-up to develop modular, mobile biomanufacturing units using single-use technologies.

FAQs:

1) What is the current market size of the Global Single-use Bioreactors Market?

The market was valued at USD 4.1 billion in 2023.

2) What is the major growth driver of the Global Single-use Bioreactors Market?

The key growth driver is the increasing demand for biologics and the shift toward cost-effective, contamination-free manufacturing solutions.

3) Which is the largest region during the forecast period in the Global Single-use Bioreactors Market?

North America held the largest market share in 2023.

4) Which segment accounted for the largest market share in the Global Single-use Bioreactors Market?

The Stirred-tank Single-use Bioreactors segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Single-use Bioreactors Market?

Key players include Sartorius AG, Thermo Fisher Scientific Inc., Danaher Corporation (Cytiva), Merck KGaA, and Eppendorf AG.